Novo Nordisk Products

FDA, Wegovy and Novo Nordisk

Shortage of Novo Nordisk's Wegovy and Ozempic drugs is resolved, FDA says

The FDA’s decision will threaten the ability of compounding pharmacies to make far cheaper, unbranded versions of the injections over the next few months.

news.bloomberglaw · 1d

Novo’s Ozempic, Wegovy Shortage Ends, Threatening Copycats (1)

Novo Nordisk A/S’s weight-loss and diabetes drugs are no longer in short supply, US regulators said, a decision that’s expected to curtail widespread access to cheaper copies of the popular medications.

USA TODAY on MSN · 1d

Generic Wegovy, Ozempic compounds may become harder to get as FDA removes drug from shortage list

Compounding pharmacies producing cheaper semaglutide products have been given notice they will soon have to stop, as the drug is no longer on the FDA shortage list.

22hon MSN

Why Novo Nordisk A/S (NVO) Surged On Friday?

We recently published a list of Five Chinese Firms Dominate Friday’s Top 10 Gainers. In this article, we are going to take a ...

1don MSN

Why Novo Nordisk Stock Popped on Friday

Novo Nordisk ( NVO 5.29%) stock ran up 3.5% through 10:05 a.m. ET Friday morning on some good news for it (and for Eli Lilly ...

FiercePharma1d

Novo Nordisk's semaglutide shortage officially concludes in the US, spelling major threat for weight loss drug compounders

Following the resolution of Eli Lilly’s tirzepatide shortage in October, the FDA has officially declared an end to the supply ...

9hon MSN

Lilly, Novo dominance to continue as TD Cowen lifts 2030 GLP-1 sales forecast by 38%

TD Cowen projects that with Eli Lilly (NYSE:LLY) and Novo Nordisk (NVO) continuing their dominance, global sales of the GLP-1 class of weight loss/obesity drugs could reach $139B by 2030, indicating ...

6don MSN

2 Important Insights From Novo Nordisk's Earnings Call

Novo Nordisk has been looking to diversify its lineup in recent years, and is developing medicines in other fields. The ...

FiercePharma10d

'We cannot stay silent': Novo Nordisk flags dangers of compounded GLP-1s following Hims & Hers Super Bowl ad

The “Check Before You Inject” ad goes on to note that some vials of compounded semaglutide “have been found to contain ...

Why Novo Nordisk Is A Strong Buy Despite Market Concerns

Novo Nordisk thrives despite competition and explore its breakthrough amycretin study. Read here to know why we rate NVO ...

Spotlight on Novo Nordisk: Analyzing the Surge in Options Activity

Having examined the options trading patterns of Novo Nordisk, our attention now turns directly to the company. This shift ...

13d

Novo Nordisk (NVO) Investors are Alerted of the Pending Class Action and are Urged to Contact BFA Law by March 25 Deadline

New York, New York-- (Newsfile Corp. - February 9, 2025) - Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Novo Nordisk (NYSE: NVO) and certain ...

Morningstar3d

Novo Nordisk AS ADR

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results